137 related articles for article (PubMed ID: 23913810)
21. p73 in apoptosis.
Stiewe T; Pützer BM
Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
[TBL] [Abstract][Full Text] [Related]
22. Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status.
Domínguez G; Silva J; Silva JM; García JM; Larrondo FJ; Vargas J; Sanfrutos L; Provencio M; España P; Bonilla F
Genes Chromosomes Cancer; 2001 Jun; 31(2):99-106. PubMed ID: 11319797
[TBL] [Abstract][Full Text] [Related]
23. Targeting p73 in cancer.
Maas AM; Bretz AC; Mack E; Stiewe T
Cancer Lett; 2013 May; 332(2):229-36. PubMed ID: 21903324
[TBL] [Abstract][Full Text] [Related]
24. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
25. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.
Sayan AE; Roperch JP; Sayan BS; Rossi M; Pinkoski MJ; Knight RA; Willis AE; Melino G
Ann N Y Acad Sci; 2007 Jan; 1095():315-24. PubMed ID: 17404044
[TBL] [Abstract][Full Text] [Related]
26. Functions, divergence and clinical value of TAp73 isoforms in cancer.
Logotheti S; Pavlopoulou A; Galtsidis S; Vojtesek B; Zoumpourlis V
Cancer Metastasis Rev; 2013 Dec; 32(3-4):511-34. PubMed ID: 23592418
[TBL] [Abstract][Full Text] [Related]
27. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
28. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
[TBL] [Abstract][Full Text] [Related]
29. p73 isoforms meet evolution of metastasis.
Logotheti S; Pavlopoulou A; Marquardt S; Takan I; Georgakilas AG; Stiewe T
Cancer Metastasis Rev; 2022 Dec; 41(4):853-869. PubMed ID: 35948758
[TBL] [Abstract][Full Text] [Related]
30. [TAp73α is Upregulated in the Most Common Human Cancers].
Iscan E; Karakülah G; Ekin U; Ozturk M; Uzuner H; Suner A
Mol Biol (Mosk); 2022; 56(2):320. PubMed ID: 35403622
[TBL] [Abstract][Full Text] [Related]
31. p73: in silico evidence for a putative third promoter region.
Sayan AE; Rossi M; Melino G; Knight RA
Biochem Biophys Res Commun; 2004 Jan; 313(3):765-70. PubMed ID: 14697257
[TBL] [Abstract][Full Text] [Related]
32. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
Tomkova K; Tomka M; Zajac V
Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
[TBL] [Abstract][Full Text] [Related]
33. Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
Anselmo NP; Rey JA; Almeida LO; Custódio AC; Almeida JR; Clara CA; Santos MJ; Casartelli C
Genet Mol Res; 2009 Oct; 8(4):1257-63. PubMed ID: 19876867
[TBL] [Abstract][Full Text] [Related]
34. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
35. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Lucena-Araujo AR; Kim HT; Thomé C; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Glória AB; Chauffaille Mde L; Athayde M; Chiattone CS; Mito I; Bendlin R; Souza C; Bortolheiro C; Coelho-Silva JL; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Blood; 2015 Nov; 126(20):2302-6. PubMed ID: 26429976
[TBL] [Abstract][Full Text] [Related]
36. Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours.
Ferru A; Denis S; Guilhot J; Gibelin H; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
Eur J Surg Oncol; 2006 Mar; 32(2):228-30. PubMed ID: 16290057
[TBL] [Abstract][Full Text] [Related]
37. [The coordinated interaction of multifunctional members of p53 family determines many key processes in multicellular organisms].
Vilgelm AE; Zaika AI; Prasolov VS
Mol Biol (Mosk); 2011; 45(1):180-97. PubMed ID: 21485507
[TBL] [Abstract][Full Text] [Related]
38. Unifying the p73 knockout phenotypes: TAp73 orchestrates multiciliogenesis.
Napoli M; Flores ER
Genes Dev; 2016 Jun; 30(11):1253-4. PubMed ID: 27298333
[TBL] [Abstract][Full Text] [Related]
39. Regulating the genome surveillance system: miRNAs and the p53 super family.
Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
[TBL] [Abstract][Full Text] [Related]
40. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
